BioMarin Pharmaceutical’s (BM8) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting BioMarin Pharmaceutical is a Sell.
BioMarin Pharmaceutical’s (BM8) 20-Day exponential moving average is 50.68, while BioMarin Pharmaceutical’s (BM8) share price is €50.88, making it a Buy.
BioMarin Pharmaceutical’s (BM8) 50-Day exponential moving average is 51.53, while BioMarin Pharmaceutical’s (BM8) share price is €50.88, making it a Sell.
BioMarin Pharmaceutical’s (BM8) 10-Day exponential moving average is 50.76, while BioMarin Pharmaceutical’s (BM8) share price is €50.88, making it a Buy.
BioMarin Pharmaceutical’s (BM8) 100-Day exponential moving average is 51.76, while BioMarin Pharmaceutical’s (BM8) share price is €50.88, making it a Sell.
BioMarin Pharmaceutical’s (BM8) stock price is €50.88 and BioMarin Pharmaceutical’s (BM8) 50-day simple moving average is 52.03, creating a Sell signal.
BioMarin Pharmaceutical’s (BM8) stock price is €50.88 and BioMarin Pharmaceutical’s (BM8) 100-day simple moving average is 53.13, creating a Sell signal.
BioMarin Pharmaceutical’s (BM8) stock price is €50.88 and BioMarin Pharmaceutical’s (BM8) 200-day simple moving average is 50.66, creating a Buy signal.